APA (7th ed.) Citation
(2026). First-in-human radiation dosimetry of the GRPR antagonist [Ga]Ga-NOTA-PEG-RM26 in patients with prostate and breast cancer. EJNMMI Research.
Chicago Style (17th ed.) Citation
"First-in-human Radiation Dosimetry of the GRPR Antagonist [Ga]Ga-NOTA-PEG-RM26 in Patients with Prostate and Breast Cancer." EJNMMI Research 2026.
MLA (9th ed.) Citation
"First-in-human Radiation Dosimetry of the GRPR Antagonist [Ga]Ga-NOTA-PEG-RM26 in Patients with Prostate and Breast Cancer." EJNMMI Research, 2026.
Warning: These citations may not always be 100% accurate.